))
Stem Cells Will Change EVERYTHING: The Future of Medicine with Mattias Bernow
Manage episode 492403316 series 3669813
Julian Issa에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Julian Issa 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Mattias Bernow is the CEO of Cellcolabs, a pioneering biotech company working to bring safe, affordable stem cell treatments to the world. His mission: to make mesenchymal stem cells (MSCs) as accessible as antibiotics—transforming how we treat aging, inflammation, and chronic disease.
In this episode, we explore how stem cells work, why their power lies in immune modulation—not cell replacement—and how regulation, manufacturing, and ethics are shaping the future of regenerative medicine.
Expect to learn:
Why Mattias believes stem cells could become the most important health technology since vaccines
How mesenchymal stem cells reduce inflammation, support healing, and improve recovery
What separates high-quality stem cells from the dangerous black-market clinics
How the industry is finally catching up to the science—especially in Japan and Korea
Why Cellcolabs uses GMP-certified, allogeneic MSCs—and what that means for your health
What Brian Johnson actually received from his stem cell protocol
And why the future of medicine could be an infusion—not an operation
⏱ Timestamps:
0:00 – Intro: Why stem cells will change medicine forever
2:00 – What antibiotics did for infections, MSCs may do for chronic disease
4:45 – Mattias’s background: medicine, business, and building Cellcolabs
8:00 – Stem cells explained like you're five: what they are and what they do
12:00 – Anti-inflammatory, regenerative, and immune-modulating effects
15:20 – The biggest problem: charlatans, regulation, and cost
18:30 – Why GMP (Good Manufacturing Practice) is non-negotiable
21:00 – The origin of Cellcolabs: pandemic, shortages, and scaling stem cells
24:45 – Japan, Korea, and the shift in global regulation
27:30 – Autologous vs allogeneic, IV vs local injection
30:00 – The real expectations: healthspan, not immortality
34:00 – What stem cell treatment might cost—and who it's for
38:00 – Why Brian Johnson chose Cellcolabs and what he got
43:00 – The stem cell misunderstanding: they don’t engraft—they signal
47:00 – Stem cells vs surgery: the survival and recovery comparison
53:00 – How this space will explode in the next 5–10 years
📸 Instagram: @thebeyondtomorrowpodcast
🌍 Website: www.beyondtomorrowpodcast.com
📩 Email: [email protected]
🎙 Hosted by Julian Issa
📍 Subscribe to The Beyond Tomorrow Podcast with Julian Issa for more stories from the edge of what’s possible
47 에피소드
공유
